Eclectic Associates’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $325K | Sell |
13,403
-409
| -3% | -$9.91K | 0.07% | 100 |
|
|
2025
Q1 | $350K | Buy |
13,812
+1,838
| +15% | +$46.6K | 0.09% | 93 |
|
|
2024
Q4 | $318K | Sell |
11,974
-929
| -7% | -$24.6K | 0.09% | 99 |
|
|
2024
Q3 | $373K | Sell |
12,903
-1,974
| -13% | -$57.1K | 0.15% | 76 |
|
|
2024
Q2 | $416K | Sell |
14,877
-919
| -6% | -$25.7K | 0.19% | 61 |
|
|
2024
Q1 | $438K | Sell |
15,796
-1,006
| -6% | -$27.9K | 0.2% | 60 |
|
|
2023
Q4 | $484K | Sell |
16,802
-8,520
| -34% | -$245K | 0.23% | 52 |
|
|
2023
Q3 | $840K | Buy |
25,322
+797
| +3% | +$26.4K | 0.43% | 39 |
|
|
2023
Q2 | $900K | Sell |
24,525
-700
| -3% | -$25.7K | 0.44% | 38 |
|
|
2023
Q1 | $1.03M | Buy |
25,225
+651
| +3% | +$26.6K | 0.53% | 35 |
|
|
2022
Q4 | $1.26M | Sell |
24,574
-292
| -1% | -$15K | 0.61% | 36 |
|
|
2022
Q3 | $1.09M | Sell |
24,866
-2,246
| -8% | -$98.3K | 0.71% | 28 |
|
|
2022
Q2 | $1.42M | Buy |
27,112
+233
| +0.9% | +$12.2K | 0.95% | 23 |
|
|
2022
Q1 | $1.39M | Buy |
26,879
+322
| +1% | +$16.7K | 0.89% | 27 |
|
|
2021
Q4 | $1.57M | Buy |
26,557
+876
| +3% | +$51.7K | 1% | 21 |
|
|
2021
Q3 | $1.11M | Buy |
25,681
+865
| +3% | +$37.2K | 0.81% | 28 |
|
|
2021
Q2 | $972K | Buy |
24,816
+464
| +2% | +$18.2K | 0.73% | 31 |
|
|
2021
Q1 | $882K | Buy |
24,352
+638
| +3% | +$23.1K | 0.73% | 32 |
|
|
2020
Q4 | $873K | Buy |
+23,714
| New | +$873K | 0.83% | 31 |
|